|1||Active, not recruiting||
An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia
Clinical Trial of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations
|3||Active, not recruiting||
Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations
† Study has passed its completion date and status has not been verified in more than two years.